New Market Study, "Mexico Pharmaceuticals & Healthcare Report Q3 2013", Has Been Published
The improving performance of Mexico's regulatory system presents more opportunities for multinational pharmaceutical companies seeking to enter the Mexican pharmaceutical market. On the back of favourable economic and political conditions, we forecast Mexico's pharmaceutical market will grow at a rate of 8.8% in 2013 in local currency terms and 14.4% in US dollar terms.
View full press release